BioCentury | Feb 4, 2013
Company News

AmorChem, McGill University, Florida Institute of Technology deal

...asthma. AmorChem said the deal will target the "animal proof of concept" of the compounds. MSBi Valorisation Inc....
BioCentury | Mar 7, 2011
Financial News

Mimetogen completes venture financing

...Date completed: 2/25/11 Type: Venture financing Raised: Not disclosed Investors: Medwell Capital Corp.; iNovia Capital; MSBi Valorisation Inc....
Items per page:
1 - 2 of 2
BioCentury | Feb 4, 2013
Company News

AmorChem, McGill University, Florida Institute of Technology deal

...asthma. AmorChem said the deal will target the "animal proof of concept" of the compounds. MSBi Valorisation Inc....
BioCentury | Mar 7, 2011
Financial News

Mimetogen completes venture financing

...Date completed: 2/25/11 Type: Venture financing Raised: Not disclosed Investors: Medwell Capital Corp.; iNovia Capital; MSBi Valorisation Inc....
Items per page:
1 - 2 of 2